A Phase I/II Dose Escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Transurethral Photodynamic Therapy With QLT0074 for Benign Prostatic Hyperplasia
Phase of Trial: Phase I/II
Latest Information Update: 22 May 2012
At a glance
- Drugs Lemuteporfin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Adverse reactions
- 22 May 2012 Actual end date (May 2005) added as reported by ClinicalTrials.gov.
- 22 May 2012 Actual initiation date (Mar 2003) added as reported by ClinicalTrials.gov.
- 01 Mar 2012 New trial record